抗氧化酶抑制剂-阿司匹林耐药性和与遗传多态度的关系:一篇综述
1Department of Emergency Medicine, Zigong First People's Hospital, Zigong City, China.
The Journal of international medical research
|February 29, 2024
概括
抗阿司匹林耐药性是心血管和脑血管疾病的原因,与基因多态性有关. 了解这些遗传变异可以改善对高危患者的抗血小板治疗指导.
科学领域:
- 心血管科学 心血管科学
- 药物基因组学 药物基因组学
- 分子生物学分子生物学
背景情况:
- 卒中是全球主要的死亡原因,阿司匹林 (乙酸) 被广泛用于预防.
- 阿司匹林耐药性,患者仍然经历缺血事件,阻碍了有效的治疗和预防策略.
- 影响阿司匹林耐药性的因素包括遗传学,药物剂量和药物相互作用.
研究的目的:
- 审查与阿司匹林耐药性相关的基因多态性.
- 阐明基因变异在抗血小板治疗失败中的作用.
- 为预防心血管和脑血管疾病提供个性化的治疗策略.
主要方法:
- 这篇叙事综述综合了关于基因多态和阿司匹林耐药性的现有研究.
- 该审查侧重于表明遗传变异与治疗结果之间存在显著关联的研究.
- 研究了阿司匹林耐药性背后的机制,包括血小板聚合途径.
主要成果:
- 各种血小板路径中的遗传多态性与阿司匹林耐药性有显著的关联.
- 这些遗传变异可以改变血小板聚合,导致阿司匹林疗效降低.
- 性别,药物剂量和代谢疾病等因素也会影响阿司匹林耐药性.
结论:
- 了解阿司匹林耐药性的机制,特别是基因多态化的作用,对于个性化医学至关重要.
- 对药物基因组学知识的提高可以为需要抗血小板治疗的人提供更准确的药物指导.
- 未来的研究应该专注于阐明特定的遗传标记,以优化阿司匹林治疗策略.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
79
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
79
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
81
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
81
Epistasis Analysis
5.5K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.5K
Epistasis
48.9K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
48.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
867
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
867
Single Nucleotide Polymorphisms-SNPs
17.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K


